International Clinical Trials Day

Event Date:
20 May 2019
10:00 to 15:00

We are celebrating International Clinical Trials Day at The Royal Marsden on Monday 20th May  

International Clinical Trials Day

We are joining with the National Institute for Health Research (NIHR) to celebrate International Clinical Trials Day at The Royal Marsden. This is a great opportunity to highlight the impact that clinical research has had on medicine to date and to showcase the wide range of studies being conducted at The Royal Marsden and in partnership with The Institute of Cancer Research, London (ICR).

Be Part of Research

To mark International Clinical Trials Day, the NIHR is launching its new Be Part of Research campaign. The campaign aims to encourage patients, carers and the public to get involved in research and will coincide with the launch of the new Be Part of Research website (formerly UK Clinical Trials Gateway), which will allow users to search for opportunities to participate in research.

On the Day

We are inviting staff, patients, carers and the public to find out more about clinical trials and will be holding events at both the Chelsea and Sutton sites. In addition to information stalls, quizzes and displays in the main foyer at Sutton and Regency Staircase in Chelsea, we will be holding a Research Café, providing a great opportunity for patients and staff to talk to those involved in running and taking part in clinical trials at The Royal Marsden.

We will also be bringing  the history of clinical trials to life, assisted by  Dr James Lind, the 18th Century naval surgeon who pioneered the first clinical trial into the causes and treatment of scurvy. Our own James Lind, dressed in period costume, will be handing out oranges throughout the day.

Clincial Trials at The Royal Marsden

At any one time, The Royal Marsden is involved in around 750 clinical trials, of which around 550 are open to recruitment, with the ultimate aim of carrying out pioneering research into the prevention, diagnosis and treatment of cancer. The Royal Marsden recieves funding for clinical trials from the BRC, in addition to the ICR and other sources.